Sageworth Trust’s Cardinal Health CAH Stock Holding History

Sageworth Trust’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1	Closed	–	–	206
2020 Q2	$0	Buy	+1	New	+$52	﹤0.01%	229

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sageworth Trust's CAH Position: Q3 2020 in Review

Sageworth Trust sold out of Cardinal Health (CAH) in Q3 2020, closing a stake of 1 share.

Sageworth Trust first reported a position in CAH in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 740 funds tracked by Wall St. Rank hold CAH as of Q3 2020.

Sageworth Trust reported no remaining Cardinal Health position as of Q3 2020 after selling out during the quarter.
Sageworth Trust sold 1 Cardinal Health share in Q3 2020.
Sageworth Trust first reported a position in Cardinal Health in Q2 2020 and held it in 1 quarter.
Sageworth Trust's Cardinal Health position peaked at $0 in Q2 2020.
740 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2020.

Based on Sageworth Trust's 13F filing for Q3 2020, filed 4 Nov 2020.